HIV treatment scheduling via robust nonlinear model predictive control

2004 5th Asian Control Conference

Volumn 1, Issue , 2004, Pages 25-32

  Zurakowski, Ryan ^a   Messina, Michael J ^a   Tuna, Sezai E ^a   Teel, Andrew R ^a  

^a University of California   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLONAL EXPANSION; CYTOTOXICITY; IMMUNE FUNCTIONS; NONLINEAR MODEL PREDICTIVE CONTROL;

ANTIGENS; CELLS; CLONING; DIFFERENTIAL EQUATIONS; DISEASES; FEEDBACK; NONLINEAR CONTROL SYSTEMS; PATIENT TREATMENT; ROBUSTNESS (CONTROL SYSTEMS); TOXICITY; VIRUSES;

PREDICTIVE CONTROL SYSTEMS;

EID: 16244369130     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: None     Document Type: Conference Paper

References (21)

1. I. E. Alcamo. AIDS: the biological basis. Jones and Bartlett, 3 edition, 2003.
2. D. Douek, J. Brenchley, M. Betts, D. Ambrozak, B. Hill, Y. Okamoto, J. Casazza, J. Kuruppu, K. Kunstman, S. Wollnsky, Z. Grossman, M. Dybul, A. Oxenlus, D. Price, M. Conners, and R. Koup. HIV preferentially infects HIV-specific CD4+ T cells. Nature, 417:95-98, 2002.
3. D. Finzi, J. Blankson, J. Siliciano, J. Margolick, K. Chadwick, T. Pierson, K. Smith, J. Lisziewicz, F. Lori, C. Flexner, T. Quinn, R. Chaisson, E. Rosenberg, B. Walker, S. Gange, J. Gallant, and R. Siliciano. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat Med, 5(5):512-7, May 1999.
4. G. Grimm, M. J. Messina, A. R. Teel, and S. E. Tuna. Model predictive control when a local control lyapunov function is not available. In Proceedings of the 2003 American Control Conference, volume 5, pages 4125-4130, June 2003.
5. G. Grimm, M. J. Messina, A. R. Teel, and S. E. Tuna. Nominally robust model predictive control with state constraints. In Proceedings of 42nd IEEE Conference on Decision and Control, volume 2, pages 1413-1418, 2003.
6. G. Grimm, M. J. Messina, S. E. Tuna, and A. R. Teel. Examples when nonlinear model predictive control is nonrobust. Automatica, 2004 (to appear).
7. T. Harrer, E. Harrer, S. Kalams, P. Barbosa, A. Trocha, R. Johnson, T. Elbeik, M. Feinberg, S. Buchbinder, and B. Walker. Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load. J Immunol, 156(7):2616-23, Apr 1996.
8. T. Harrer, E. Harrer, S. Kalams, T. Elbeik, S. Staprans, M. Feinberg, Y. Cao, D. Ho, T. Yilma, A. Caliendo, R. Johnson, S. Buchbinder, and B. Walker. Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection. AIDS Res Hum Retroviruses, 12(7):585-92, May 1996.
9. A. Jadbabaie, J. Yu, and J. Hauser. Unconstrained receding-horizon control of nonlinear systems. IEEE Transactions on Automatic Control, 46(5):776-783, 2001.
10. C. Manegold, C. Hannoun, A. Wywiol, M. Dietrich, S. Polywka, C. Chiwakata, and S. Gnther. Reactivation of hepatitis B virus replication accompanied by acute hepatitis in patients receiving highly active antiretroviral therapy. Clin Infect Dis, 32(1):144-8, Jan 2001.
11. D. Mayne, J. B. Rawlings, C. V. Rao, and P. Scokaert. Constrained model predictive control: Stability and optimality. Automatica, 36:789-814, 2000.
12. M. Messina, S. Tuna, and A. Teel. Robust stabilization of discrete-time nonlinear systems by certainty equivalence output feedback with applications to model predictive control. In Proceedings of the 2004 American Control Conference, June 2004 (to appear).
13. A. Mocroft, L. Ruiz, P. Reiss, B. Ledergerber, C. Katlama, A. Lazzarin, F.-D. Goebel, A. N. Phillips, B. Clotet, J. D. Lundgren, and J. D. Lundgren. Virological rebound after suppression on highly active antiretroviral therapy. AIDS, 17(12): 1741-51, Aug 2003.
14. M. G. Omerod, editor. Flow cytometry: a practical approach. Oxford University Press, 3 edition, 2000.
15. A. N. Phillips, S. Staszewski, F. Lampe, M. S. Youle, S. Klauke, M. Bickel, C. A. Sabin, H. W. Doerr, M. A. Johnson, C. Loveday, V. Miller, V. Miller, and V. Miller. 400 copies/mL during initial highly active antiretroviral therapy regimens, according to prior nucleoside experience and duration of suppression. J Infect Dis, 186(8):1086-91, Oct 2002.
16. A. R. Teel. Discrete time receding horizon optimal control: is the stability robust? In M. S. de Queiroz, M. Malisoff, and P. Wolenski, editors, Optimal Control, Stabilization and Nonsmooth Analysis, volume 301 of Lecture Notes in Control and Information Sciences. Springer, 2004.
17. D. Wodarz. Helper-dependent vs. helper-independent CTL responses in HIV infection: implications for drug therapy and resistance. J Theor Biol, 213(3):447-59, Dec 2001.
18. D. Wodarz and M. Nowak. Specific therapy regimes could lead to long-term immunological control of HIV. Proc Natl Acad Sci USA, 96(25):14464-9, Dec 1999.
19. R. Zurakowski and A. R. Teel. Enhancing immune response to HIV infection using MPC-based treatment scheduling. In Proceedings of the 2003 American Control Conference, volume 2, pages 1182-1187, June 2003.
20. R. Zurakowski and A. R. Teel. A model predictive control based scheduling method for HIV therapy. IEEE Transaction on Biomedical Engineering, 2004 (submitted).
21. R. Zurakowski, A. R. Teel, and D. Wodarz. Utilizing alternate target cells in treating HIV infection through scheduled treatment interruptions. In Proceedings of the 2004 American Control Conference, June 2004 (to appear).